Metabolism of hCG and hLH to multiple urinary forms

[1]  S. Birken,et al.  Isolation and characterization of human pituitary chorionic gonadotropin. , 1996, Endocrinology.

[2]  P. Jones,et al.  Prevalence of an immunological LH β‐subunit variant in a UK population of healthy women and women with polycystic ovary syndrome , 1995, Clinical endocrinology.

[3]  H. Cuckle,et al.  Urinary multiple marker screening for down's syndrome , 1995, Prenatal diagnosis.

[4]  B. Weintraub,et al.  Asparagine-linked oligosaccharide structures determine clearance and organ distribution of pituitary and recombinant thyrotropin. , 1995, Endocrinology.

[5]  T. Koizumi,et al.  Combination Assay of Urinary β‐Core Fragment of Human Chorionic Gonadotropin with Serum Tumor Markers in Gynecologic Cancers , 1995, Japanese journal of cancer research : Gann.

[6]  M. Yoshimura,et al.  Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro. , 1995, Cancer research.

[7]  I. Huhtaniemi,et al.  Occurrence and biological properties of a common genetic variant of luteinizing hormone. , 1995, The Journal of clinical endocrinology and metabolism.

[8]  P. Neven,et al.  Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance. , 1995, British Journal of Cancer.

[9]  L. Cole,et al.  Immunological recognition and clinical significance of nicked human chorionic gonadotropin in testicular cancer. , 1994, Clinical chemistry.

[10]  P. Neven,et al.  The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix. , 1994, Gynecologic oncology.

[11]  J U Baenziger,et al.  Protein‐specific glycosyltransferases: how and why they do it! , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  R. Canfield,et al.  Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. , 1994, Endocrine reviews.

[13]  H. Cuckle,et al.  Urinary β‐core human chorionic gonadotrophin: A new approach to Down's syndrome screening , 1994, Prenatal diagnosis.

[14]  N. Tsubota,et al.  Assessment of urinary β‐core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer , 1994, Cancer.

[15]  E. Chatzaki,et al.  Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium. , 1994, British Journal of Cancer.

[16]  T. Yamada,et al.  Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions. , 1994, Biochemical and biophysical research communications.

[17]  R. Canfield,et al.  Development, characterization, and application of monoclonal antibodies to the native and synthetic beta COOH-terminal portion of human chorionic gonadotropin (hCG) that distinguish between the native and desialylated forms of hCG. , 1994, Endocrinology.

[18]  P. Neven,et al.  Diurnal variation of urinary "hCG beta subunit core fragment" production evaluated in patients with gynecological neoplasms. , 1994, Clinical chemistry.

[19]  L. Cole,et al.  Urine hCG beta-subunit core fragment, a sensitive test for ectopic pregnancy. , 1994, The Journal of clinical endocrinology and metabolism.

[20]  R. Norman,et al.  Molecular heterogeneity of the β-core fragment of human chorionic gonadotrophin , 1993 .

[21]  P. Neven,et al.  The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses. , 1993, Gynecologic oncology.

[22]  S. Dharmesh,et al.  Estrogen modulates expression of the glycosyltransferases that synthesize sulfated oligosaccharides on lutropin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Birken,et al.  Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples. , 1993, Endocrinology.

[24]  W. Collins,et al.  Substantial urinary concentrations of material resembling beta-core fragment of chorionic gonadotropin beta-subunit in mid-menstrual cycle. , 1993, Clinical chemistry.

[25]  R. Canfield,et al.  Structure and significance of human luteinizing hormone-beta core fragment purified from human pituitary extracts. , 1993, Endocrinology.

[26]  P. Neven,et al.  Urinary chorionic gonadotropin subunits and β‐core in nonpregnant women. A study of benign and malignant gynecologic disorders , 1993, Cancer.

[27]  L. Cole,et al.  Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine. , 1993, American journal of obstetrics and gynecology.

[28]  R. Norman,et al.  Beta-core fragment of human chorionic gonadotropin in cervical intraepithelial neoplasia (CIN). , 1993, Gynecologic oncology.

[29]  K. Pettersson,et al.  Concanavalin A affinity chromatography of human serum gonadotropins: evidence for changes of carbohydrate structure in different clinical conditions. , 1993, The Journal of clinical endocrinology and metabolism.

[30]  G. Bousfield,et al.  Equine lutropin and chorionic gonadotropin bear oligosaccharides terminating with SO4-4-GalNAc and Sia alpha 2,3Gal, respectively. , 1993, The Journal of biological chemistry.

[31]  T. Chard,et al.  Human chorionic gonadotrophin and subunit composition of maternal serum and coelomic and amniotic fluids in the first trimester of pregnancy. , 1992, The Journal of endocrinology.

[32]  G. Bousfield,et al.  Reduction and reoxidation of equine gonadotropin alpha-subunits. , 1992, Endocrinology.

[33]  R. Norman,et al.  Distribution of the β-core human chorionic gonadotrophin fragment in human body fluids , 1992 .

[34]  C. Haglund,et al.  Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. , 1992, Clinical chemistry.

[35]  R. Norman,et al.  Comparison of specific immunoassays for detection of the beta-core human chorionic gonadotrophin fragment in body fluids. , 1992, The Journal of endocrinology.

[36]  C. Haglund,et al.  Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. , 1992, Cancer research.

[37]  C. Matthews,et al.  Urinary Concentrations of Beta Core Fragment of hCG Throughout Pregnancy , 1992, Obstetrics and gynecology.

[38]  B. Malassagne,et al.  Free Human Chorionic Gonadotropin β Subunit in Gonadal and Nongonadal Neoplasms , 1992 .

[39]  T. Chard,et al.  Immunoreactive beta-core-like material in normal postmenopausal urine: human chorionic gonadotrophin or LH origin? Evidence for the existence of LH core. , 1992, The Journal of endocrinology.

[40]  K. Kanazawa,et al.  Carbohydrate structures of beta-core fragments of human chorionic gonadotropin isolated from a pregnant individual. , 1992, Endocrinology.

[41]  S. Kumar,et al.  Circulatory half-life but not interaction with the lutropin/chorionic gonadotropin receptor is modulated by sulfation of bovine lutropin oligosaccharides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  I. Huhtaniemi,et al.  An immunologically anomalous luteinizing hormone variant in a healthy woman. , 1992, The Journal of clinical endocrinology and metabolism.

[43]  L. Cole,et al.  Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit. , 1992, Clinical chemistry.

[44]  O. Hindsgaul,et al.  A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAcβ1, 4GlcNAcβ1,2Manα that mediates rapid clearance of lutropin , 1991, Cell.

[45]  I. Huhtaniemi,et al.  Monoclonal antibody-based discrepancies between two-site immunometric tests for lutropin. , 1991, Clinical chemistry.

[46]  L. Cole,et al.  The heterogeneity of human chorionic gonadotropin (hCG). II. Characteristics and origins of nicks in hCG reference standards. , 1991, Endocrinology.

[47]  L. Cole,et al.  The heterogeneity of human chorionic gonadotropin (hCG). I. Characterization of peptide heterogeneity in 13 individual preparations of hCG. , 1991, Endocrinology.

[48]  T. Chard,et al.  The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women. , 1991, The Journal of endocrinology.

[49]  L. Cole,et al.  The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. , 1991, Endocrinology.

[50]  R. Canfield,et al.  Development and Characterization of a New, Highly Specific Antibody to the Human Chorionic Gonadotropin-β Fragment* , 1991 .

[51]  P. Snyder,et al.  Secretion of chorionic gonadotropin by cultured human pituitary cells. , 1990, The Journal of clinical endocrinology and metabolism.

[52]  D. Blithe,et al.  Human chorionic gonadotrophin-like and beta-core-like materials in postmenopausal urine. , 1990, The Journal of endocrinology.

[53]  D. Blithe,et al.  Disparity between β-Core Levels in Pregnancy Urine and Serum: Implications for the Origin of Urinary β-Core , 1990 .

[54]  J. Bidart,et al.  Occurrence of fragmentation of free and combined forms of the beta-subunit of human chorionic gonadotropin. , 1990, Endocrinology.

[55]  D. Kaetzel,et al.  The sialylated oligosaccharides of recombinant bovine lutropin modulate hormone bioactivity. , 1990, The Journal of biological chemistry.

[56]  D. Blithe,et al.  Carbohydrate Composition of β-Core , 1989 .

[57]  T. Kitajima,et al.  Molecular Forms of Human Chorionic Gonadotropin in Choriocarcinon Serum and Urine , 1989, Japanese journal of cancer research : Gann.

[58]  D. Blithe,et al.  Metabolic fate of human choriogonadotropin. , 1989, Journal of steroid biochemistry.

[59]  D. Blithe,et al.  Metabolic Clearance Rate and Urinary Clearance of Purified β-Core , 1989 .

[60]  W. Odell,et al.  Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle. , 1989, The Journal of clinical endocrinology and metabolism.

[61]  B. A. Keel.  Microheterogeneity of Glycoprotein Hormones , 1988 .

[62]  L. Cole,et al.  Origin and Occurrence of Human Chorionic Gonadotropin β-Subunit Core Fragment , 1988 .

[63]  J. Bidart,et al.  Characterization of a cleavage product in the human choriogonadotropin β-subunit , 1988 .

[64]  R. Canfield,et al.  Preparation and Characterization of Antibodies to the Urinary Fragment of the Human Chorionic Gonadotropin β-Subunit* , 1988 .

[65]  L. Cole,et al.  Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. , 1988, Endocrinology.

[66]  N. Kochibe,et al.  Altered Glycosylation Is Induced in Both α- and β-Subunits of Human Chorionic Gonadotropin Produced by Choriocarcinoma , 1988 .

[67]  M. Mochizuki,et al.  Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. , 1988, The Journal of biological chemistry.

[68]  D. Blithe,et al.  Purification of β-Core Fragment from Pregnancy Urine and Demonstration That Its Carbohydrate Moieties Differ from Those of Native Human Chorionic Gonadotropin-β , 1988 .

[69]  W. Odell,et al.  Pulsatile secretion of human chorionic gonadotropin in normal adults. , 1987, The New England journal of medicine.

[70]  T. Kitajima,et al.  Characterization of human chorionic gonadotropin in urine of patients with trophoblastic diseases by Western blotting using specific antibodies. , 1987, Japanese journal of cancer research : Gann.

[71]  G. Bousfield,et al.  Sulfate and phosphate analysis in glycoproteins and other biologic compounds using ion chromatography. Application to glycoprotein hormones and sugar esters. , 1987, Journal of chromatography.

[72]  R. Lewis,et al.  A single amino acid substitution in an ectopic alpha subunit of a human carcinoma choriogonadotropin. , 1986, The Journal of biological chemistry.

[73]  A. Kobata,et al.  Comparison of carbohydrate structure between human chorionic gonadotropin present in urine of patients with trophoblastic diseases and healthy individuals. , 1985, Japanese journal of cancer research : Gann.

[74]  A. Kobata,et al.  Detection of incompletely sialylated human chorionic gonadotropin by peanut agglutinin in choriocarcinoma. , 1985, The Japanese journal of experimental medicine.

[75]  S. Amr,et al.  Metabolism, distribution and excretion of purified human chorionic gonadotropin and its subunits in man. , 1984, Annales d'endocrinologie.

[76]  R. Canfield,et al.  Mixing two monoclonal antibodies yields enhanced affinity for antigen. , 1982, Journal of immunology.

[77]  B. Nisula,et al.  Metabolic and renal clearance rates of purified human chorionic gonadotropin. , 1981, The Journal of clinical investigation.

[78]  D. Bangham,et al.  International Reference Preparation of Human Chorionic Gonadotrophin for Immunoassay: potency estimates in various bioassay and protein binding assay systems; and International Reference Preparations of the alpha and beta subunits of human chorionic gonadotrophin for immunoassay. , 1980, The Journal of endocrinology.

[79]  G T Ross,et al.  A new reference preparation of human chorionic gonadotrophin and its subunits. , 1976, Bulletin of the World Health Organization.